The study found that diosmin treatment significantly reduced the growth and size of HCC tumors and decreased the levels of various tumor markers, including alpha‐fetoprotein (AFP) and vascular endothelial growth factor (VEGF). This evidence concerns the gene AFP and hepatocellular carcinoma.